Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

Syndax (SNDX) announced that multiple abstracts evaluating revumenib, an oral small molecule menin inhibitor, have been accepted for oral ...

Gil Blum, an analyst from Needham, maintained the Buy rating on Autolus Therapeutics (AUTL – Research Report). The associated price ...

The FDA approved obecabtagene autoleucel for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.

The FDA granted accelerated approval to asciminib for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. The approval is based on data from a ...

AP = Accelerated phase; BP = Blastic phase; CML = Chronic myeloid leukemia. *Careful consideration of the various differing factors, such as patient selection criteria, response criteria and ...

Officials claim a Alicia Campbell, of Mays Landing, claimed her child needed special treatment at a leukemia center in Texas ...

Good day, everyone, and welcome to the Syndax Third Quarter 2024 Earnings Conference Call. Today's call is being recorded. All participants have been placed in a listen-only mode. You'll have an ...

Although polycythemia vera management remains focused on reducing the risk of thrombotic events, there is growing recognition ...